NCT00648830View on ClinicalTrials.gov

Comparative Bioavailability Study of Clarithromycin 250 mg Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Healthy
Interventions
PROCEDURE

Clarithromycin

Single-dose of Clarithromycin 250 mg oral immediate-release tablets

DRUG

Clarithromycin

single-dose 250 mg immediate-release oral tablets

Trial Locations (1)

H7V 4B4

Algorithme Pharma, Montreal

Sponsors

Collaborators (1)

Genpharm ULC
All Listed Sponsors
collaborator

Genpharm ULC

INDUSTRY

lead

Mylan Pharmaceuticals Inc

INDUSTRY